Part 1 of the Patents Act and Living Organisms Study Series
Quick Answer
Biotechnology uses living systems, organisms or their derivatives to make or modify products and processes. In India, biotechnology inventions may be patented when they satisfy novelty, inventive step and industrial applicability and are not excluded by Sections 3 or 4 of the Patents Act, 1970. Plants, animals, natural discoveries and essentially biological processes remain outside patent protection.
Biotechnology combines biology with technology to improve medicine, agriculture, industry and environmental management. Traditional examples include fermentation and selective breeding. Modern biotechnology extends much further through genetic engineering, molecular biology, bioinformatics and synthetic biology.
Patents Act and Living Organisms Complete Study Series
- Biotechnology and Patentability in India
- Status of Biotechnology Patents in India
- Evergreening, Sui Generis Protection and Pharmaceutical Patents
What is biotechnology?
The Convention on Biological Diversity defines biotechnology as a technological application that uses biological systems, living organisms or their derivatives to make or modify products or processes for a specific use.
In practical terms, biotechnology includes:
- genetic modification of organisms;
- manipulation of DNA and RNA;
- production of vaccines and therapeutic proteins;
- diagnostic kits;
- industrial fermentation;
- biodegradable materials and biofuels; and
- bioinformatics and synthetic biology.
Its applications extend across medicine, agriculture, environmental protection and industry.
Why are patents important in biotechnology?
Biotechnology research often requires substantial time, expertise and investment. Patent protection can help an inventor recover that investment by granting, for a limited period, the right to prevent others from carrying out the acts reserved to the patentee.
An invention must satisfy the requirements of novelty, inventive step and capability of industrial application under Section 2(1)(j) of the Patents Act, 1970.
Applying these requirements to biotechnology is difficult because many biotechnology products originate in nature. A discovery of a natural phenomenon is not the same as an invention. The central question is whether human intervention has produced a new and useful technical result rather than merely revealing what already exists.
Which biotechnology inventions may be patentable in India?
Subject to the statutory requirements and exclusions, patent protection may be available for:
- genetically modified or human-made microorganisms that do not occur naturally;
- biotechnological processes, such as recombinant methods used to produce insulin, enzymes or vaccines;
- engineered biological material with a disclosed function and industrial application;
- novel vaccine compositions and diagnostic products; and
- industrial or environmental applications involving microorganisms, waste treatment, bioenergy or bio-based materials.
The IP India Guidelines for Examination of Biotechnology Applications provide practical guidance for examining such applications.
Key distinction: A vaccine product or diagnostic kit may be patentable if it satisfies the Act, but a method of medical treatment is excluded by Section 3(i).
What biotechnology subject matter is not patentable?
Several exclusions in Section 3 directly affect biotechnology.
| Provision | Main exclusion | Biotechnology relevance |
|---|---|---|
| Section 3(b) | Inventions contrary to public order or morality, or seriously harmful to life, health or the environment | May cover ethically unacceptable genetic manipulation |
| Section 3(c) | Mere discovery of a scientific principle, living thing or non-living substance occurring in nature | Prevents patents over mere natural discoveries |
| Section 3(d) | New forms of known substances without the required enhancement of efficacy | Important for pharmaceutical biotechnology |
| Section 3(i) | Methods of treatment of humans or animals | Excludes therapeutic and specified diagnostic treatment methods |
| Section 3(j) | Plants and animals, their parts, seeds, varieties, species and essentially biological processes, except microorganisms | Creates the principal boundary for agricultural biotechnology |
Plants and plant varieties are not protected through patents in India. Plant varieties may instead receive protection under the Protection of Plant Varieties and Farmers' Rights Act, 2001.
What international rules affect biotechnology patents?
The TRIPS Agreement requires patent protection to be available across fields of technology, subject to recognised exceptions. Article 27.3(b) permits members to exclude plants and animals other than microorganisms and allows plant varieties to be protected through patents, an effective sui generis system or a combination of both.
The Budapest Treaty simplifies patent procedures involving microorganisms by recognising a deposit made with an international depositary authority.
What ethical and legal concerns arise?
Biotechnology patents raise questions about whether life forms or genetic material should be privately controlled. Broad patents may restrict research, affect access to healthcare or place pressure on farmers and biological resources.
Biopiracy is another concern. It involves the use of biological resources or traditional knowledge without proper recognition or benefit-sharing. The neem, turmeric and basmati controversies are commonly studied examples. India uses the Biological Diversity Act and the Traditional Knowledge Digital Library alongside patent law to address these concerns.
Important biotechnology patent cases
Dimminaco AG v Controller of Patents
The Calcutta High Court accepted that a process producing a vaccine containing living organisms was not automatically excluded from patentability merely because the end product contained living material. The case is important for the patentability of biotechnology processes in India.
Diamond v Chakrabarty
The United States Supreme Court treated a genetically engineered bacterium as patentable because it was produced through human ingenuity and possessed characteristics not found in nature.
Association for Molecular Pathology v Myriad Genetics
The United States Supreme Court held that naturally occurring DNA is not patentable merely because it has been isolated, while artificially created complementary DNA may be treated differently.
These foreign decisions are influential for understanding the discovery-invention distinction, but Indian patentability must be decided under the Indian statute.
Key Takeaways
- Biotechnology uses living systems for useful products and processes.
- Human technical intervention is central to biotechnology patentability.
- Microorganisms and biotechnology processes may be patented if all requirements are met.
- Plants, animals, natural discoveries and treatment methods are excluded in India.
- Patent law operates alongside biodiversity, farmers' rights and traditional-knowledge protection.
Frequently Asked Questions
Can a living organism be patented in India?
Not every living organism can be patented. Section 3(j) excludes plants and animals but preserves an exception for microorganisms. The claimed microorganism must still satisfy the ordinary patentability requirements and must not be a mere discovery from nature.
Can a naturally occurring gene be patented?
A mere discovery of a naturally occurring gene is excluded. A biotechnology claim involving engineered material, a defined technical function and industrial application must be examined on its precise facts and claims.
Are genetically modified plants patentable in India?
Plants, seeds and plant varieties are excluded by Section 3(j). Plant varieties are dealt with under the PPVFR Act.
Are vaccines patentable?
A novel vaccine composition or production process may be patentable. A method of medical treatment remains subject to Section 3(i).
Why is the Budapest Treaty relevant?
It allows a single recognised deposit of a microorganism to be used for patent procedures in contracting states, subject to the applicable rules.